Prophylaxis use among males with haemophilia B in the United States-Reference-Cited by-同舟云学术

Prophylaxis use among males with haemophilia B in the United States

Published:2017-08-06 Issue:6 Volume:23 Page:910-917
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Ullman M.¹^ORCID,Zhang Q. C.²,Grosse S. D.³,Recht M.⁴,Soucie J. M.⁵,

Affiliation:

1. Gulf States Hemophilia & Thrombophilia Center; University of Texas Health Science Center at Houston; Houston TX USA

2. Division of Human Development and Disability; National Center on Birth Defects and Developmental Disabilities; CDC; Atlanta GA USA

3. National Center on Birth Defects and Developmental Disabilities; CDC; Atlanta GA USA

4. The Hemophilia Center at Oregon Health & Science University; Portland OR, USA

5. Division of Blood Disorders; National Center on Birth Defects and Developmental Disabilities; CDC; Atlanta GA USA

Funder

Centers for Disease Control and Prevention

Hemophilia Treatment Center Network (HTCN)

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.13317/fullpdf

Reference28 articles.

1. National Hemophilia Foundation MASAC recommendations concerning prophylaxis (regular administration of clotting factor concentrate to prevent bleeding) http://www.hemophilia.org

2. World Federation of Hemophilia Guidelines for the management of hemophilia http://www.wfh.org

3. Twenty-five years' experience of prophylactic treatment in severe hemophilia A and B;Nilsson;J Int Med,1992

4. A longtudinal study of orthopedic outcomes for severe factor-VIII-deficient haemophiliacs;Aledort;J Int Med,1994

5. Benefits of prophylaxis versus on-demand treatment in adolescents and adults with severe haemophilia A: the POTTER study;Tagliferri;Thromb and Haemost,2015

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Racial and ethnic differences in reported haemophilia death rates in the United States;Haemophilia;2023-09-17

2. Gene therapy preferences and informed decision‐making: Results from a National Hemophilia Foundation Community Voices in research survey;Haemophilia;2022-12-05

3. Health care resource utilization and cost burden of hemophilia B in the United States;Blood Advances;2021-04-08

4. Evaluation of CDC’s Hemophilia Surveillance Program — Universal Data Collection (1998–2011) and Community Counts (2011–2019), United States;MMWR. Surveillance Summaries;2020-09-04

5. Diagnosis and Management of a Patient with Newly Diagnosed Hemophilia B;Pediatric Bleeding Disorders;2020